Disclosures for "Feasibility of at-home motor assessments using wireless technology in patients with myelopathy: year 1 follow up of CYGNET, an observational study of patients with adrenomyeloneuropathy")
-
The institution of Dr. Bergner has received research support from Deutsche Forschungsgemeinschaft .
-
Wolfgang Koehler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Minoryx. Wolfgang Koehler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil. Wolfgang Koehler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for United Leukodystrophy Foundation. Wolfgang Koehler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for European Leukodystrophy Association. The institution of Wolfgang Koehler has received research support from Minoryx. The institution of Wolfgang Koehler has received research support from Vigil. The institution of Wolfgang Koehler has received research support from SwanBio. The institution of Wolfgang Koehler has received research support from Alexion.
-
Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebird bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn. Dr. Bonkowsky has received stock or an ownership interest from Orchard. The institution of Dr. Bonkowsky has received research support from NIH. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
-
Dr. Stephen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
-
Dr. Paker has received personal compensation for serving as an employee of SwanBio Therapeutics.
-
An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Glenn has nothing to disclose.
-
Dr. Zelenkofske has received personal compensation for serving as an employee of SwanBio Therapeutics. Dr. Zelenkofske has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for DinaQor .
-
Dr. Engelen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Engelen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueBirdBio. Dr. Engelen has received personal compensation in the range of $0-$499 for serving as a Consultant for SwanBio. The institution of Dr. Engelen has received research support from SwanBio. The institution of Dr. Engelen has received research support from BlueBirdBio. The institution of Dr. Engelen has received research support from Autobahn. The institution of Dr. Engelen has received research support from Minoryx. The institution of Dr. Engelen has received research support from Netherlands Organization for Scientific Research.